Colony-stimulating factors and antibiotics—a new prospect in treating infectious diseases?

This publication has 25 references indexed in Scilit:

• Granulocyte colony-stimulating factor improves survival rate and reduces concentrations of bacteria, endotoxin, tumor necrosis factor, and endothelin-1 in fulminant intra-abdominal sepsis in rats
  Critical Care Medicine, 1996
• White cell enhancement in the treatment of severe candidosis
  The Lancet, 1995
• Synergy of simultaneous administration of ofloxacin and granulocyte colony-stimulating factor in killing ofEscherichia coli by human neutrophils
  Infection, 1995
• Antifungal combination therapy with granulocyte colony-stimulating factor and fluconazole in experimental disseminated candidiasis
  European Journal of Clinical Microbiology & Infectious Diseases, 1995
• Improved survival in simulated surgical infection with combined cytokine, antibiotic and immunostimulant therapy
  British Journal of Surgery, 1994
• Effects of granulocyte-macrophage colony-stimulating factor on wound contraction
  European Journal of Clinical Microbiology & Infectious Diseases, 1994
• Beneficial effect of granulocyte colony-stimulating factor in an infant withPasteurella multocida brain abscess
  European Journal of Pediatrics, 1993
• Hyperimmune human IgG or recombinant human granulocyte-macrophage colony-stimulating factor as adjunctive therapy for group B streptococcal sepsis in newborn rats
  The Journal of Pediatrics, 1993
• Enhancement of in vitro bactericidal activity of neutrophils from trauma patients in the presence of granulocyte colony-stimulating factor
  European Journal of Clinical Microbiology & Infectious Diseases, 1993
• Therapeutic efficacy of granulocyte colony stimulating factor against rat cecal ligation and puncture model
  The International Journal of Cell Cloning, 1993